Memorial Sloan Kettering Physician-Scientists Develop Innovative Multimodal Machine Learning Model That Improves Prediction of Metastatic Breast Cancer Treatment Options
December 14, 2024
December 14, 2024
NEW YORK, Dec. 14 (TNSres) -- The Memorial Sloan Kettering Cancer Center issued the following news release:
New research presented during the 2024 San Antonio Breast Cancer Symposium (SABCS) reveals a new machine learning model that could change the way metastatic breast cancer is treated in the future. By combining clinical and genomic data, physician-scientists from Memorial Sloan Kettering Cancer Center (MSK) developed a tool that could help improve predictions of how people with . . .
New research presented during the 2024 San Antonio Breast Cancer Symposium (SABCS) reveals a new machine learning model that could change the way metastatic breast cancer is treated in the future. By combining clinical and genomic data, physician-scientists from Memorial Sloan Kettering Cancer Center (MSK) developed a tool that could help improve predictions of how people with . . .